...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What's the deal with Zenith?

IMHO,  anything DM says at AGM is just trying to get some excitement as a saleman which he is.

If any BP deal whether a royalty deal, license, or partnership does occur in 2023 it will come out of the nowhere .  The more quiet Zenith  is the better. If there was a non binding term sheet on a royalty deal for Zenith than he could talked about it at the AGM. So imo it just an ideal at this point or ,maybe a few meeting with pharma discussing it . Rumours are just rumours until they are not....

Share
New Message
Please login to post a reply